Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | TGM2 | P21980 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL718911 | 0.77 | ALDH1A1 (0.40) | ALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL285817 | 0.76 | THRB (0.38) | ALDH1A1CYP3A4CYP2C9CYP2C19TGM2 | |
| SCHEMBL717487 | 0.68 | TGM2 (0.46) | ALDH1A1CYP3A4CYP2C9CYP2C19TGM2 | |
| SCHEMBL285591 | 0.67 | TDP1 (0.41) | ALDH1A1 | |
| SCHEMBL27500604 | 0.67 | ALDH1A1 (0.37) | ALDH1A1CYP2C19 | |
| SCHEMBL720462 | 0.66 | ELANE (0.35) | ALDH1A1 | |
| SCHEMBL717492 | 0.66 | CYP2C19 (0.43) | ALDH1A1CYP3A4CYP2C9CYP2C19TGM2 | |
| SCHEMBL18725316 | 0.66 | ALDH1A1 (0.39) | ALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL27486237 | 0.65 | ALDH1A1 (0.40) | ALDH1A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL285265 | 0.65 | TDP1 (0.47) | ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8729203-B2 | Polymer composition | CONTAMAC LIMITED (GB) | 2014-05-20 | — | — | US | disclosed |
| US-20120053313-A1 | POLYMER COMPOSITION | CONTAMAC LIMITED (GB) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053313-A1 | POLYMER COMPOSITION | UACA, CRYAA, CRYZ | ALDH1A1 3560/4885CYP3A4 2502/4885CYP2C9 1195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.